WYNZORA^{® New}

Wynzora® (calcipotriene and betamethasone dipropionate) Cream is indicated for the topical treatment of plaque psoriasis in patients 18 years of age and older.

For additional safety and other information, please see Prescribing Information for WYNZORA

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.